Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.5.2169

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing miRNA Expression Profiles  

Liu, Yong-Qi (Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University)
Li, Yi (Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University)
Qin, Jie (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
Wang, Qian (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
She, Ya-Li (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
Luo, Ya-Li (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
He, Jian-Xin (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
Li, Jing-Ya (Institute of Systems Biology and TCM Transformation, Gansu Traditional Chinese Medical University)
Xie, Xiao-Dong (Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.5, 2014 , pp. 2169-2177 More about this Journal
Abstract
Matrine, a main active component extracted from dry roots of Sophora flavecens, has been reported to exert antitumor effects on A549 human non-small lung cancer cells, but its mechanisms of action remain unclear. To determine effects of matrine on proliferation of A549 cells and assess possible mechanisms, MTT assays were employed to detect cytotoxicity, along with o flow cytometric analysis of DNA content of nuclei of cells following staining with propidium iodide to analyze cell cycle distribution. Western blotting was performed to determined expression levels of Bax, Bcl-2, VEGF and HDAC1, while a microarray was used to assessed changes of miRNA profiles. In the MTT assay, matrine suppressed growth of human lung cancer cell A549 in a dose- and timedependent manner at doses of 0.25-2.5 mg/ml for 24h, 48h or 72h. Matrine induced cell cycle arrest in G0/G1 phase and decreased the G2/M phase, while down-regulating the expression of Bcl2 protein, leading to a reduction in the Bcl-2/Bax ratio. In addition, matrine down regulated the expression level of VEGF and HDAC1 of A549 cells. Microarray analysis demonstrated that matrine altered the expression level of miRNAs compared with untreated control A549 cells. In conclusion, matrine could inhibit proliferation of A549 cells, providing useful information for understanding anticancer mechanisms.
Keywords
Matrine; A549 lung cancer cells; miRNA profile; apoptosis; proliferation;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Zhang JP, Zhang M, Jin C, et al (2001a). Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin, 22, 765-8.
2 Zhang JP, Zhang M, Zhou JP, et al (2001b). Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin, 22, 183-6.
3 Zhang L, Wang T, Wen X, et al (2007). Effect of matrine on HeLa cell adhesion and migration. Eur J Pharmacol, 563, 69-76.   DOI   ScienceOn
4 Zhang LP, Jiang JK, Tam JW, et al (2001c). Effects of matrine on proliferation and differentiation in K-562 cells. Leukemia Res, 25, 793-800.   DOI   ScienceOn
5 Zhang P, Wang Z, Chong T, Ji Z (2012a). Matrine inhibits proliferation and induces apoptosis of the androgenindependent prostate cancer cell line PC-3. Mol Med Re, 5, 783-7.
6 Tan C, Qian X, Jia R, Wu M, Liang Z (2013). Matrine induction of reactive oxygen species activates p38 leading to caspasedependent cell apoptosis in non-small cell lung cancer cells. Oncol Rep, 30, 2529-35.
7 Sasaki H, Moriyama S, Nakashima Y, et al (2004). Histone deacetylase 1 mRNA expression in lung cancer. Lung Cancer, 46, 171-8.   DOI   ScienceOn
8 Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF (2003). Apoptosis and lung cancer: a review. J Cell Biochem, 88, 885-98.   DOI   ScienceOn
9 Takamizawa J, Konishi H, Yanagisawa K, et al (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 64, 3753-6.   DOI   ScienceOn
10 Thiagalingam S, Cheng KH, Lee HJ, et al (2003). Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci, 983, 84-100.   DOI   ScienceOn
11 Thorburn A (2004). Death receptor-induced cell killing. Cell Signal, 16, 139-44.   DOI   ScienceOn
12 Weichert W, Roske A, Gekeler V, et al (2008a). Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol, 9, 139-48.   DOI   ScienceOn
13 Tsang WP, Kwok TT (2009). The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis, 30, 953-9.   DOI   ScienceOn
14 Ulasli SS, Celik S, Gunay E, et al (2013). Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo (a)pyrene. Asian Pac J Cancer Prev, 14, 6159-64.   과학기술학회마을   DOI   ScienceOn
15 Wang JS, Ji AF, Wan HJ, et al (2012). Gene silencing of betacatenin by RNAi inhibits proliferation of human esophageal cancer cells by inducing G0/G1 cell cycle arrest. Asian Pac J Cancer Prev, 13, 2527-32.   과학기술학회마을   DOI   ScienceOn
16 Liu XS, Jiang J, Jiao XY, Wu YE, Lin JH (2006). Matrineinduced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways. Planta Med, 72, 501-6.   DOI
17 Liu XY, Fang H, Yang ZG, et al (2008). Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol, 47, 448-56.   DOI
18 Liang J, Qian Y, Xu D, Yin Q, Pan HJ (2013). Serum tumor markers, hypoxia-inducible factor-1alpha HIF-1alpha and vascular endothelial growth factor, in patients with nonsmall cell lung cancer before and after intervention. Asian Pac J Cancer Prev, 14, 3851-4.   과학기술학회마을   DOI   ScienceOn
19 Liu ZY, Zhang GL, Wang MM, Xiong YN, Cui HQ (2011). MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pac J Cancer Prev, 12, 2819-23.
20 Liu J, Zhu M, Shi R, Yang M (2003). Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med, 31, 337-54.   DOI
21 Long Y, Lin XT, Zeng KL, Zhang L (2004). Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreat Dis Int, 3, 69-72.
22 Luo C, Zhu Y, Jiang T, et al (2007). Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology, 229, 245-52.   DOI
23 Minamiya Y, Ono T, Saito H, et al (2011). Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung. Lung Cancer, 74, 300-4.   DOI   ScienceOn
24 Nakagawa M, Oda Y, Eguchi T, et al (2007). Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep, 18, 769-74.
25 Nana-Sinkam SP, Geraci MW (2006). MicroRNA in lung cancer. J Thorac Oncol, 1, 929-31.   DOI
26 Krusche CA, Wulfing P, Kersting C, et al (2005). Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res Treat, 90, 15-23.   DOI
27 Kallsen K, Andresen E, Heine H (2012). Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells. PloS One, 7, e50000.   DOI
28 Jiang H, Hou C, Zhang S, et al (2007). Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol, 559, 98-108.   DOI
29 Jiang QQ, Liu B, Yuan T (2013). MicroRNA-16 inhibits bladder cancer proliferation by targeting cyclin D1. Asian Pac J Cancer Prev, 14, 4127-30.   과학기술학회마을   DOI   ScienceOn
30 Johnson SM, Grosshans H, Shingara J, et al (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-47.   DOI   ScienceOn
31 Langer R, Mutze K, Becker K, et al (2010). Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study. J Clin Pathol, 63, 994-8.   DOI
32 Lee EM, Shin S, Cha HJ, et al (2009). Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med, 24, 45-50.
33 Li N, Tie XJ, Liu PJ, et al (2013a). Effects of down-regulation of HDAC6 expression on proliferation, cell cycling and migration of esophageal squamous cell carcinoma cells and related molecular mechanisms. Asian Pac J Cancer Prev, 14, 685-9.   과학기술학회마을   DOI   ScienceOn
34 Li Y, Zhang S, Geng JX, Hu XY (2013b). Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev, 14, 4599-2.   과학기술학회마을   DOI   ScienceOn
35 Fritzsche FR, Weichert W, Roske A, et al (2008). Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer, 8, 381.   DOI
36 Eder M, Scherr M (2005). MicroRNA and lung cancer. N Engl J Med, 352, 2446-8.   DOI   ScienceOn
37 Gregory RI, Shiekhattar R (2005). MicroRNA biogenesis and cancer. Cancer Res, 65, 3509-12.   DOI   ScienceOn
38 Erridge SC, Moller H, Price A, Brewster D (2007). International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol, 4, 570-7.   DOI   ScienceOn
39 Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.   DOI   ScienceOn
40 Green DR, Kroemer G (2004). The pathophysiology of mitochondrial cell death. Science, 305, 626-9.   DOI
41 Hengartner MO (2000). The biochemistry of apoptosis. Nature, 407, 770-6.   DOI   ScienceOn
42 Hernandez-Hernandez OT, Camacho-Arroyo I (2013). Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF. Mini Rev Med Chem, 13, 635-42.   DOI
43 Hu MJ, Zeng H, Wu YL, et al (2005). Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice.Chin J Dig Dis, 6, 68-71.   DOI   ScienceOn
44 Hu ZL, Zhang JP, Qian DH, et al (1996). Effects of matrine on mouse splenocyte proliferation and release of interleukin-1 and -6 from peritoneal macrophages in vitro. Zhongguo Yao Li Xue Bao, 17, 259-61.
45 Jiang C, Yang YF, Cheng SH (2004). Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther, 4, 33-9.   DOI   ScienceOn
46 Bremnes RM, Camps C, Sirera R (2006). Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer, 51, 143-58.   DOI   ScienceOn
47 Cai X, Gao S, Cai J, Wu Y, Deng H (2009). Artesunate induced morphological and mechanical changes of Jurkat cell studied by AFM. Scanning, 31, 83-9.   DOI
48 Ai J, Gao HH, He SZ, et al (2001). Effects of matrine, artemisinin, tetrandrine on cytosolic [Ca2+]i in guinea pig ventricular myocytes. Acta Pharmacol Sin, 22, 512-5.
49 Antignani A, Youle RJ (2006). How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol, 18, 685-9.   DOI
50 Blower PE, Chung JH, Verducci JS, et al (2008). MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther, 7, 1-9.
51 Cheng H, Xia B, Zhang L, et al (2006). Matrine improves 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice. Pharmacol Res, 53, 202-8.   DOI
52 Cordes N, Beinke C, Plasswilm L, van Beuningen D (2004). Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta (1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro. Strahlenther Onkol, 180, 157-64.   DOI
53 Cress WD, Seto E (2000). Histone deacetylases, transcriptional control, and cancer. J cell Physiol, 184, 1-16.   DOI
54 Croce CM, Calin GA (2005). miRNAs, cancer, and stem cell division. Cell, 122, 6-7.   DOI   ScienceOn
55 Zhu W, He J, Chen D, et al (2014). Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. PloS One, 9, e87780.   DOI
56 Yao Q, Sun JG, Ma H, et al (2014). Monitoring microRNAs Using a Molecular Beacon in CD133+/ CD338+ Human Lung Adenocarcinoma-initiating A549 Cells. Asian Pac J Cancer Prev, 15, 161-6.   과학기술학회마을   DOI   ScienceOn
57 Zhang QC, Jiang SJ, Zhang S, Ma XB (2012b). Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. Asian Pac J Cancer Prev, 13, 3471-6.   과학기술학회마을   DOI   ScienceOn
58 Zhang S, Cheng B, Li H, et al (2014). Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway. Mol Biol Rep, Epub ahead of print.
59 Zhang S, Qi J, Sun L, et al (2009). Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Molec Biol Reports, 36, 791-9.   DOI
60 Weichert W, Roske A, Niesporek S, et al (2008b). Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res, 14, 1669-77.   DOI   ScienceOn
61 Xu CQ, Dong DL, Du ZM, et al (2004). Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866. Yao Xue Xue Bao, 39, 691-4 (in Chinese).
62 Yang Y, Liu L, Zhang Y, et al (2014). MiR-503 targets PI3K p85 and IKK-beta and suppresses progression of non-small cell lung cancer. Int J Cancer, Epub ahead of print.
63 Zhang BH, Wang NS, Li XJ, Kong XJ, Cai YL (1990). Antiarrhythmic effects of matrine. Zhongguo Yao Li Xue Bao, 11, 253-7 (in Chinese).
64 Chang C, Rao DL, Qiu XM, Wang H, Xiong L (2014). [The inhibitory effect of matrine on the growth of human colorectal cancer HT29 cells: an experimental observation]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 34, 62-5.